[{"NetIncomeLoss_1_Q1_USD":-74930000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":637000.0,"InterestPaidNet_1_Q1_USD":3375000.0,"InventoryFinishedGoods_0_Q1_USD":2979000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":121000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2420000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":28004000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":57.37,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":576768.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":12948000.0,"AssetsCurrent_0_Q1_USD":558132000.0,"LongTermDebt_0_Q1_USD":198563000.0,"NoninterestExpense_1_Q1_USD":3689000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":58966000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":584000.0,"NoninterestIncome_1_Q1_USD":329000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7332669.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1110000.0,"LossContingencyLossInPeriod_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":12584000.0,"CommonStockSharesIssued_0_Q1_shares":62240050.0,"LossContingencyAccrualProvision_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":426184000.0,"Assets_0_Q1_USD":649898000.0,"ShareBasedCompensation_1_Q1_USD":19948000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":50085000.0,"RestrictedCashCurrent_0_Q1_USD":2420000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":28845000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":62101070.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":415000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":50857000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":42.51,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":120566000.0,"InventoryRawMaterials_0_Q1_USD":10632000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-3566000.0,"CommonStockValue_0_Q1_USD":62000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1404000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":41493.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-9276000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1780000.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":36736000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":430000000.0,"CostsAndExpenses_1_Q1_USD":110407000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1569000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-75111000.0,"OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":1211000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":445310000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":77862000.0,"Liabilities_0_Q1_USD":286703000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-2904000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-181000.0,"OperatingLeaseLiability_0_Q1_USD":82899000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":426063000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":29134000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":8937000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AvailableForSaleSecuritiesGrossUnrealizedGains_1_Q1_USD":121000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":765000.0,"CommonStockSharesOutstanding_0_Q1_shares":62240050.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":11307000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1897000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":20378000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-181000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-79256000.0,"InventoryWorkInProcess_0_Q1_USD":28656000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":12222000.0,"LiabilitiesCurrent_0_Q1_USD":58967000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-49472000.0,"AccountsPayableCurrent_0_Q1_USD":10376000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":26000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":447730000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":15554000.0,"LongTermDebtNoncurrent_0_Q1_USD":149052000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":884000.0,"InterestExpenseDebt_1_Q1_USD":45563000.0,"AdditionalPaidInCapital_0_Q1_USD":1424411000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":389448000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":47763.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":2558000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"ReceivablesNetCurrent_0_Q1_USD":18265000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":38050000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1061399000.0,"VariableLeaseCost_1_Q1_USD":700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3814842.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":237000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":37667000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":13368000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2041000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-8544000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"OperatingIncomeLoss_1_Q1_USD":-71364000.0,"InventoryNet_0_Q1_USD":42267000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":44.48,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":23.24,"OperatingLeaseCost_1_Q1_USD":3200000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":649898000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":14709000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":19948000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":-1897000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":49357000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5037000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":447730000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.21,"OtherLiabilitiesNoncurrent_0_Q1_USD":822000.0,"StockholdersEquity_0_Q1_USD":363195000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1130000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":150000000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-75000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":39043000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":5199000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]